CoChat

Chapter 2 Epidemiology of sarcopenia

Shimokata, Hiroshi, Shimada, Hiroyuki, Satake, Shosuke, Endo, Naoto, Shibasaki, Koji, Ogawa, Sumito, Arai, Hidenori · 2018 · Geriatrics & Gerontology International
Cited by 38

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

The prevalence of sarcopenia depends on the definition applied and the attributes of the target population. EWGSOP, International Working group on Sarcopenia1 and Asian Working Group for Sarcopenia (AWGS2 released papers for the purpose of establishing international consensus and minimizing the differences between the various definitions of sarcopenia, and the prevalence of sarcopenia provided with the EWGSOP's definition (1–29%) was used.1 Reports from Japan were included among the reports reviewed, and the prevalence of sarcopenia was estimated to be between 11 and 24%. The prevalence of sarcopenia in Asia was also reported to be relatively high. However, as a result of a subsequent large-scale survey targeting Japanese, the prevalence of sarcopenia was found to be between 7.5% (n = 4811)3 and 8.2% (n = 1099).4 As such, whether sarcopenia can be particularly prevalent in Asia remains unclear.3, 4 Based on the results of a systematic review of recent studies regarding the prevalence of sarcopenia, the prevalence of this condition when defined as a decrease in skeletal muscle mass (skeletal muscle index [SMI]) was between 6.0% and 59.8%, and was between 7.5% and 77.6% when defined as a decrease in gait speed and grip strength, as in the EWGSOP definition. Both results clearly show the broad range of figures provided to describe the prevalence of sarcopenia.5 In addition, the prevalence of sarcopenia depends largely on the characteristics of the individuals. Among senior citizens residing in care facilities, the prevalence can range between 14 and 33%,1 and when this population also includes a large proportion of individuals with disabilities or those hospitalized to recover or undergo rehabilitative care, the prevalence rate is estimated to be 78%.6 Based on the above, specifying the prevalence of sarcopenia is difficult, because determining the presence of this condition depends on the definition applied and the individual attributes of the individuals. However, when reviewing the results of large-scale studies involving 1000 or more participants, the prevalence rate is estimated to be between 6% and 12%,3, 7, 8 which is generally considered to be the typical prevalence of sarcopenia. The causes of sarcopenia are divided into two broad classifications: primary sarcopenia, which are age-related changes leading to sarcopenia, and secondary sarcopenia, which consists of factors other than aging that can lead to sarcopenia, such as inadequate physical activity, other underlying diseases or malnutrition (Table 1).9 Age-related background factors for primary sarcopenia include decreased numbers of muscle satellite cells and motor neurons, decreased hormone secretion (human growth hormone, testosterone, ghrelin etc.), increased production of inflammatory cytokines, diminished mitochondrial function, abnormal myokine production, and weight loss accompanying decreased appetite, among various others. The deterioration of the body's capacity to synthesize muscle proteins and their increased degradation as a result of these factors are speculated to be related to the sarcopenia disease state.10, 11 With regard to secondary sarcopenia arising from inadequate exercise, many studies have found that skeletal muscle mass can decrease as a result of a lack of physical activity, whereas muscle hypertrophy can occur as a result of physical training. Increased quantities of nitrogen and potassium in skeletal muscle tissue, as well as decreased skeletal muscle mass, were observed after being bedridden for 6–7 weeks. Muscle strength in the lower extremities particularly decreased markedly by approximately 20%.12 Underlying conditions leading to secondary sarcopenia include organ failure, inflammatory diseases, malignant cancers and endocrine disorders, among others.9 In addition, because patients are forced to rest due to disease onset rather than the disease itself, this reduced activity can lead to the development of sarcopenia. Nutrition-related causes of secondary sarcopenia include deficient protein and branched-chain amino acid intake, as well as deficient intake of foods containing large quantities of anti-oxidants, such as n-3 long-chain polyunsaturated fatty acids, vitamins and carotenoids.10 The influence of aging on resting muscle protein synthesis and degradation is small13 and decreases in skeletal muscle mass occurring with age are thought to be the result of reductions in factors that stimulate protein synthesis as a result of inadequate exercise and malnutrition. Amino acid intake is effective for supporting muscle protein synthesis, but this effect is also dose-dependent, and in healthy adult men who do not exercise regularly, maintaining high concentrations of amino acids in the blood increases transport of amino acids to muscle cells; rapid stimulation of muscle protein synthesis and anabolic activity have been reported to result from increasing free amino acid concentration.14 This clinical question summarize

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ggi.13320

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

Metadata

Authors
Shimokata, H., Shimada, H., Satake, S., Endo, N., Shibasaki, K., Ogawa, S., & Arai, H.
Venue
Geriatrics & Gerontology International
Publisher
Wiley
Published
2018-05
Volume
18
Issue
S1
Pages
13-22
ISSN
  • 1444-1586 (ISSN-L)
  • 1447-0594
OpenAlex
W2801424482
Cited by
38
References
14
FWCI
3.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.